Switch to:

Denali Therapeutics Net Income

: $-55.2 Mil (TTM As of Jun. 2019)
View and export this data going back to 2017. Start your Free Trial

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Denali Therapeutics's net income for the three months ended in Jun. 2019 was $-58.3 Mil. Its net income for the trailing twelve months (TTM) ended in Jun. 2019 was $-55.2 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Denali Therapeutics's Earnings per Share (Diluted) for the three months ended in Jun. 2019 was $-0.61.


Denali Therapeutics Net Income Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Denali Therapeutics Annual Data
Dec15 Dec16 Dec17 Dec18
Net Income -16.79 -86.65 -88.19 -36.24

Denali Therapeutics Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
Net Income Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -54.72 -35.37 77.53 -38.99 -58.34

Denali Therapeutics Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Denali Therapeutics's Net Income for the fiscal year that ended in Dec. 2018 is calculated as

Net Income(A: Dec. 2018 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-36.24+0+0+0
=-36.2

Denali Therapeutics's Net Income for the quarter that ended in Jun. 2019 is calculated as

Net Income(Q: Jun. 2019 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-58.65+0.313+0+-7.1054273576E-15
=-58.3

Net Income for the trailing twelve months (TTM) ended in Jun. 2019 was -35.371 (Sep. 2018 ) + 77.533 (Dec. 2018 ) + -38.992 (Mar. 2019 ) + -58.337 (Jun. 2019 ) = $-55.2 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Denali Therapeutics  (NAS:DNLI) Net Income Explanation

Net income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Denali Therapeutics's Earnings per Share (Diluted) (EPS) for the quarter that ended in Jun. 2019 is calculated as

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Denali Therapeutics Net Income Related Terms


Denali Therapeutics Net Income Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)